Literature DB >> 26909372

Supporting data for the MS identification of distinct transferrin glycopeptide glycoforms and citrullinated peptides associated with inflammation or autoimmunity.

A Rosal-Vela1, A Barroso2, E Giménez2, S García-Rodríguez2, V Longobardo3, J Postigo4, M Iglesias4, A Lario3, J Merino4, R Merino5, M Zubiaur1, V Sanz-Nebot2, J Sancho1.   

Abstract

This data article presents the results of all the statistical analyses applied to the relative intensities of the detected 2D-DiGE protein spots for each of the 3 performed DiGE experiments. The data reveals specific subsets of protein spots with significant differences between WT and CD38-deficient mice with either Collagen-induced arthritis (CIA), or with chronic inflammation induced by CFA, or under steady-state conditions. This article also shows the MS data analyses that allowed the identification of the protein species which serve to discriminate the different experimental groups used in this study. Moreover, the article presents MS data on the citrullinated peptides linked to specific protein species that were generated in CIA(+) or CFA-treated mice. Lastly, this data article provides MS data on the efficiency of the analyses of the transferrin (Tf) glycopeptide glycosylation pattern in spleen and serum from CIA(+) mice and normal controls. The data supplied in this work is related to the research article entitled "identification of multiple transferrin species in spleen and serum from mice with collagen-induced arthritis which may reflect changes in transferrin glycosylation associated with disease activity: the role of CD38" [1]. All mass spectrometry data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with identifiers PRIDE: PXD002644, PRIDE: PXD002643, PRIDE: PXD003183 and PRIDE: PXD003163.

Entities:  

Keywords:  Arthritis; CD38; Citrullination; Glycosylation; Inflammation; Protein species; Transferrin

Year:  2016        PMID: 26909372      PMCID: PMC4731419          DOI: 10.1016/j.dib.2015.12.045

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications table Value of the data Application of μLC–TOF–MS for characterization of multiple glycopeptide glycoforms from mouse transferrin. Investigation of altered transferrin glycopeptide glycosylation patterns in inflammatory and/or autoimmune diseases. Mass spectrometry approach to identify new citrullinated peptides in mice with arthritis (CIA model). Properly described approach for 2D-DiGE analysis to identify protein species that differ in abundance due to certain pathologies. Basis for the study of altered protein species associated with inflammatory processes or arthritis in humans.

Data

Fig. 1 shows the extracted ion chromatograms (EICs) obtained by µLC–TOF–MS for the most abundant glycopeptide glycoforms of Tf isolated from WT non-immunized serum, Tf standard in a 2D gel, and Tf from a spleen extract in a 2D gel. Table 1, Table 2 in excel format show the list of the protein species identified by MS/MS, displaying the sequence of matched and fragmented peptides of a given protein. Table 3 shows the list of protein species identified by PMF. Table 4, Table 5, Table 6, Table 7, Table 8, Table 9, include the results of all the statistical analyses applied to the relative intensities of the detected 2D-DiGE protein spots for each of the 3 performed DiGE experiments. Table 10a, Table 10b shows the identities of the citrullinated peptides linked to specific protein species in CIA+, or CFA-treated mice. Table 11 shows the peptide coverage of mouse Tf standard digested with trypsin, and Table 12 shows the normalized peak area and %RSD of Tf glycopeptide glycoforms detected by µLC–TOF–MS in the spots of spleen protein extracts subjected to 2D electrophoretic separation and in-gel tryptic digestion.
Fig. 1

Extracted ion chromatograms (EICs) for the most abundant glycopeptide glycoforms of Tf isolated from (a) WT non-immunized serum, (b) Tf standard in a 2D gel (spot 3), and (c) Tf from a spleen extract in a 2D gel (spot 537 equivalent pI to spot 3) by µLC–TOF–MS.

Table 1

Protein spots from mouse spleen identified by MS/MS using the 4800 MALDI-TOF/TOF (AB Sciex).

Spot numberaIdentificationAccessionAccension numberbProtein scoreProtein score CI%cPep.countTotal ion scoredTotal %ion CIMW (theorical)eIEP (theorical)e
533SerotransferrinTRFE_MOUSEQ921I11191001169100.00078840.56.94
537SerotransferrinTRFE_MOUSEQ921I121710018109100.00078840.56.94
539SerotransferrinTRFE_MOUSEQ921I146110025266100.00078840.56.94
614Stress-induced-phosphoprotein 1STIP1_MOUSEQ608642771001914610063,1706.40
692Fibrinogen beta chainFIBB_MOUSEQ8K0E88001002557810055401.96.68
697CatalaseCATA_MOUSEP242701791001013110060012.77.72
778Alpha enolaseENOA_MOUSEP171828911002759410047453.36.37
Beta enolaseENOB_MOUSEP21550250100622410047337.46.73
Gamma enolaseENOG_MOUSEP171839410057510047609.14.99
906Voltage-dependent anion selective channel protein 2VDAC2_MOUSEQ60930179100119510032339.807
981Proteasome subunit alpha type-1PSA1_MOUSEQ9R1P442610010350100.00029812.96
982Carbonic anhydrase 2CAH2_MOUSEP0092047810017295100.00029128.56.49
Carbonic anhydrase 1CAH1_MOUSEP136342031007155100.00028360.26.44
1001Proteasome subunit alpha type-6PSA6_MOUSEQ9QUM933510010264100.00027,8116.34
Pyridoxine-5′-phosphate oxidasePNPO_MOUSEQ91XF08199.99955799.99930437.18.46
1063Flavin reductaseBLVRB_MOUSEQ923D277710016583100.00022297.46.49
1097ATP synthase subunit d, mitochondrialATP5H_MOUSEQ9DCX224310010156100.00018794.65.52
1103Ferritin light chain 1FRIL1_MOUSEP2939158510014435100.00020846.55.66
Ferritin light chain 2FRIL2_MOUSEP499452761009202100.00020886.96.39
1136Peptidyl-prolyl cis-trans isomerase APPIA_MOUSEP177423401001024910018130.90008
1147Actin-related protein 2/3 complex subunit 5-like proteinARP5L_MOUSEQ9D898165100611610017026.806.32
1171Nucleoside diphosphate kinase ANDKA_MOUSEP1553265410013518100.00017310.96.84
Nucleoside diphosphate kinase BNDKB_MOUSEQ017683301007278100.00017,4666.97
1184Protein S100-A9S10A9_MOUSEP317259510018910013,2116.64
1313Protein S100-A8S10A8_MOUSEP270051461003119100.00010345.15.43

The sequence of matched and fragmented peptides of the identified proteins, plus the ion scores and confidence intervals of the fragmented peptides can be found in the online version of this article (Table 1, .xlsx file) as supplementary material.

Spots are named as indicated on the 2-DE gel shown in Fig. 1 in Ref [1].

UniProtKB/Swiss-Prot accession number, MASCOT protein score, protein score confidence interval (C.I. %), total ion score, and total ion score confidence interval (C.I. %) are reported for the combined search of MALDI-TOF/TOF MS and MS/MS data (GPS Software, Applied Biosystems).

For protein scores, only confidence intervals above 99% were considered as statistically significant.

For total ion scores, only confidence intervals above 95% were considered as statistically significant.

Theoretical molecular weights and isoelectric points are given for each protein.

Table 2

Protein spots identified by MS/MS using the MALDI-TOF/TOF UltrafleXtreme (Bruker).

Spot numberaIdentificationAccessionAccession numberbProtein scoreSequence coverage (%)No. of peptidesMW (theorical)cIEP (theorical)c
501Aconitate hydratase, mitochondrialACON_MOUSEQ99KI093.053.60285,4008.08
538SerotransferrinTRFE_MOUSEQ921I196.654378,8416.94
539SerotransferrinTRFE_MOUSEQ921I1190.905.9478,8416.94
554Far upstream element-binding protein 1FUBP1_MOUSEQ91WJ832.752.00168,6687.74
633Fibrinogen alpha chainFIBA_MOUSEE9PV24123.514.20388,1175.77
638Heterogeneous nuclear ribonucleoprotein LHNRPL_MOUSEQ8R08169.554.60264,5508.33
732Coronin-1CORO1A_MOUSEgi|4895037102.32.2151,6276.05
738VimentinVIME_MOUSEP20152286.8316.10553,7125.06
770Protein disulfide-isomerase A6 precursorPDIA6_MOUSEgi|58037267117.7810.6349,0585.05
898Actin, cytoplasmic 1ACTB_MOUSEP60710177.479.10242,0525.29
Beta-actin-like protein 2ACTBL_MOUSEQ8BFZ3129.629.00242,3195.30
F-actin-capping protein subunit alpha-1CAZA1_MOUSEP4775392.049.80233,0905.34
972Tropomyosin alpha-1 chainTPM1_MOUSEP5877159.034.90132,7184.69
981Proteasome subunit alpha type-1PSA1_MOUSEQ9R1P4133.7813.7329,8136.00
1001Proteasome subunit alpha type-6PSA6_MOUSEQ9QUM9177.7916.3427,8116.34
1049Proteasome subunit beta type-10PSB10_MOUSEO35955109.48.80329,3306.40
Growth factor receptor-bound protein 2GRB2_MOUSEQ60631103.4711.50325,3365.89
1103Ferritin light chain 1FRIL1_MOUSEP2939148.364.4120,8475.66
1150E3 ubiquitin-protein ligase RNF181RN181_MOUSEQ9CY6226.014.80119,4875.65
1173Ubiquitin-conjugating enzyme E2 NUBE2N_MOUSEP61089104.7919.70217,1846.13
1302N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming)ACY3_MOUSEQ91XE423.112.50135,7205.30

The sequence of matched and fragmented peptides plus the ion scores and confidence intervals of the fragmented peptides can be found in the online version of this article (Table 2, .xlsx file) as supplementary material.

Spots are named as indicated on the 2-DE gel shown in Fig. 1 in Ref [1].

UniProtKB/Swiss-Prot or NCBI accession number.

Theoretical molecular weights and isoelectric points are given for each protein.

Table 3

Protein spots identified by PMF using the MALDI-TOF/TOF UltrafleXtreme (Bruker).

Spot numberaProtein nameAccession numberbMW(theorical)cIEP(theorical)cScoreExpectSequence coverageQueries matchedQueries searched
572Prelamin-A/C isoform A precursor (MS)gi|16228737074,4786.54770.0034291873
Prelamin-A/C isoform C (MS)gi|16176066765,4646.37690.02331773
Fibroblast growth factor 22 (MS)gi|1296362718,97211.73720.011611073
983Mitochondrial peptide methionine sulfoxide reductaseQ9D6Y726,2008.6760.0004234.3737
1104Low molecular weight phosphotyrosine protein phosphataseQ9D35818,6366.3058.52.40E−0231.6535

Spots are named as indicated on the 2-DE gel shown in Fig. 1 in Ref [1].

UniProtKB/Swiss-Prot or NCBI accession number.

Theoretical molecular weights and isoelectric points are given for each protein.

Table 4

Spleen protein species that differ in abundance by 2-ANOVA-Mouse in Col II immunized CD38 KO mice versus B6 WT mice.

DeCyder spot no.Protein nameaPvalue (2-ANOVA-Mouse)
B6 WT:
538Serotransferrin3.99E−04
633Fibrinogen alpha chain6.11E−04
692Fibrinogen beta chain1.12E−03
1097ATP synthase subunit d, mitochondrial1.30E−03
1302N-acyl-aromatic-L-amino acid1.75E−03
amidohydrolase (carboxylate-forming)
539Serotransferrin3.53E−03
533Serotransferrin8.87E−03
554Far upstream element-binding protein 19.53E−03
537Serotransferrin1.61E−02
501Aconitate hydratase, mitochondrial1.78E−02
1171Nucleoside diphosphate kinase A0.0195
Nucleoside diphosphate kinase B
1103Ferritin light chain 12.06E−02
Ferritin light chain 2
1300Not identified0.023
638Heterogeneous nuclear ribonucleoprotein L2.89E−02
572Prelamin-A/C isoform A precursor (PMF)3.59E−02
Prelamin-A/C isoform C (PMF)
Fibroblast growth factor 22 (PMF)
1313Protein S100-A80.05
CD38 KO:
898Actin, cytoplasmic 26.70E−03
Beta-actin-like protein 2
F-actin-capping protein subunit alpha-1
982Carbonic anhydrase 28.98E−03
Carbonic anhydrase 1
1044Not identified0.0202
981Proteasome subunit alpha type-12.39E−02

Protein name according to UniProt, or to NCBI.

Table 5

Spleen protein species that differ in abundance by 2-ANOVA-Arthritis test in Col II-immunized CIA+ versus CIA− mice.

DeCyder spot no.Protein nameaPvalue (2-ANOVA-Arthritis)
In CIA+:
438Not identified0.0162
1150E3 ubiquitin-protein ligase RNF1810.0414







In CIA:
1157Not identified0.021
778Alpha-enolase0.0365
Beta-enolase
Gamma-enolase

Protein Name according to UniProt, or to NCBI.

Table 6

Spleen protein species that differ in abundance by 2-ANOVA-Interaction in two groups of Col.II-immunized mice (CD38 KO and B6 WT) with two conditions: CIA+ and CIA−).

DeCyderspot no.Protein nameaPvalue(2-ANOVA-Mouse)Pvalue(2-ANOVA-Arthritis)Pvalue(2-ANOVA-Interaction)
1302N-acyl-aromatic-L-amino acid1.75E−030.5351.27E−04
amidohydrolase (carboxylate-forming)
532Not identified0.0650.5855.29E−04
538Serotransferrin3.99E−040.2558.40E−03
982Carbonic anhydrase 28.98E−030.7718.99E−03
Carbonic anhydrase 1
1001Proteasome subunit alpha type-60.8780.3039.65E−03
Pyridoxine-5׳-phosphate oxidase
983Mitochondrial peptide methionine0.5450.8493.57E−02
sulfoxide reductase (PMF)
1063Flavin reductase0.7070.7790.0362
537Serotransferrin1.61E−020.3064.07E−02

Protein name according to UniProt, or to NCBI.

Table 7

Differences in spleen protein species abundance compared between Col II immunized CD38 KO mice (test group) versus Col II-immunized B6 WT mice (control group).

DeCyder spot no.Protein nameaAverage ratiobPvalue (t-test)
Decreased abundance
633Fibrinogen alpha chain−1.351.67E−04
692Fibrinogen beta chain−1.194.53E−04
1097ATP synthase subunit d, mitochondrial−1.254.95E−04
538Serotransferrin−1.231.35E−03
539Serotransferrin−1.292.25E−03
533Serotransferrin−1.394.17E−03
554Far upstream element-binding protein 1−1.175.26E−03
501Aconitate hydratase, mitochondrial−1.179.81E−03
1103Ferritin light chain 1−1.370.0124
Ferritin light chain 2
638Heterogeneous nuclear ribonucleoprotein L−1.230.0142
537Serotransferrin−1.250.0208
572Prelamin-A/C isoform A precursor (MS)−1.180.0209
Prelamin-A/C isoform C (MS)
Fibroblast growth factor 22 (MS)
1171Nucleoside diphosphate kinase A−1.170.0258
Nucleoside diphosphate kinase B
697Catalase−1.160.0453
536Not identified−1.140.0475
1300Not identified−1.330.0493









Increased abundance
898Actin, cytoplasmic 21.194.37E−03
Beta-actin-like protein 2
F-actin-capping protein subunit alpha-1
1044Not identified1.250.0163
981Proteasome subunit alpha type-11.270.0194
982Carbonic anhydrase 21.160.0457
Carbonic anhydrase 1

Protein name according to UniProt, or to NCBI.

Negative average ratios indicate decreased protein abundance, while positive ratios indicate increased protein abundance in CIA+ CD38 KO relative to that in CIA+ B6 WT mice.

Table 8

Chronic inflammation model. Differences in spleen protein species abundance compared between CFA/IFA-treated CD38 KO mice (test group) and CFA/IFA-treated B6 WT mice (control group).

DeCyder spot no.Protein nameaAverage ratiobP value (t-test)
Decreased abundance
1049Proteasome subunit beta type-10−1.184.06E−03
Growth factor receptor-bound protein 2
1330Not identified−1.310.0106
972Tropomyosin alpha-1 chain−1.110.0163
1173Ubiquitin-conjugating enzyme E2 N−1.130.0217
1103Ferritin light chain 1−1.620.0343
Ferritin light chain 2
738Vimentin−1.220.0351
1104Low molecular weight phosphotyrosine
protein phosphatase (PMF)−1.280.0384
732Coronin-1−1.10.0434
Increased abundance
1313Protein S100-A81.370.0236

Protein name according to UniProt, or to NCBI.

Negative average ratios indicate decreased protein abundance, while positive ratios indicate increased protein abundance in CFA/IFA-treated CD38 KO relative to that in CFA/IFA-treated B6 WT mice.

Table 9

Non-immunized control mice. Differences in spleen protein species abundance compared between non-immunized CD38 KO mice (test group) and non-immunized B6 WT mice (control group).

DeCyder spot no.Protein nameaAverage ratiobPvalue (t-test)
Decreased abundance
538Serotransferrin−1.264.04E−03
539Serotransferrin−1.230.0185
537Serotransferrin−1.220.0221
638Heterogeneous nuclear ribonucleoprotein L−1.130.0266
770Protein disulfide-isomerase A6−1.110.0437
532Not identified−1.20.0477
Increased abundance
1295Not identified1.330.0162

Protein name according to UniProt, or to NCBI.

Negative average ratios indicate decreased protein abundance, while positive ratios indicate increased protein abundance in CFA/IFA-treated CD38 KO relative to that in CFA/IFA-treated B6 WT mice.

Table 10a

Citrullinated protein species and peptidesa detected in spleen from collagen-induced arthritis, or CFA-treated mice. TOF/TOF 4800.

Spot numberIdentificationAccesionAccension numberProtein scoreProtein score CI%Pep. countTotal ion scoreTotal % ion CIMW (theoretical)IEP (theoretical)

537SerotransferrinTRFE_MOUSEQ921I117210020107100.0078840.506.94
614Stress-induced-phosphoprotein 1STIP1_MOUSEQ6086423810027145100.0063169.606.40
697CatalaseCATA_MOUSEQ8C6E317410015131100.0060082.807.73
778Alpha enolaseENOA_MOUSEP1718294010033675100.0047453.306.37
Beta enolaseENOB_MOUSEP2155026010012224100.0047337.406.73
Gamma enolaseENOG_MOUSEP171831021001075100.0047609.104.99
981Proteasome subunit alpha type-1PSA1_MOUSEQ9R1P441510014350100.0029812.906.00
Proteasome subunit alpha typePSMA1_MOUSEQ8BTU539910012349100.0029732.805.78
1001Proteasome subunit alpha type-6PSA6_MOUSEQ9QUM932510013264100.0027811.006.34
Pyridoxine-5׳-phosphate oxidasePNPO_MOUSEQ91XF08199.999557100.0030437.108.46
1103Ferritin light chain 2FRIL2_MOUSEP4994525110010202100.0020886.906.39
1136Peptidyl-prolyl cis–trans isomerase APPIA_MOUSEP1774232010011249100.0018130.907.74
1171Nucleoside diphosphate kinase ANDKA_MOUSEP1553272610017591100.0017310.906.84
Nucleoside diphosphate kinase BNDKB_MOUSEQ017683211009278100.0017466.006.97

The sequence of matched citrullinated peptides of a given protein, and the positions of the deiminated arginines are shown in online version of this article as Supplementary material (Table 10, xlsx. File).

Table 10b

Citrullinated protein species and peptidesa detected in spleen from collagen-induced arthritis, or CFA-treated mice. TOF/TOF UltrafleXtreme.

Spot numberProtein nameAccessionAccesion numberMW (theoretical)IEP (theoretical)ScoreSequence coverage (%)Queries matchedQueries searched

633Fibrinogen alpha chainFIBA_MOUSEE9PV2487.405.78101.0017.001526
732Coronin-1ACOR1A_MOUSEO8905351.006.0483.4036.001675
898F-actin-capping protein subunit alpha-1CAZA1_MOUSEP4775332.905.3477.9043.001265
972Tropomyosin alpha-3 chainTPM3_MOUSEP2110733.004.6860.5038.601040

The sequence of matched citrullinated peptides of a given protein, and the positions of the deiminated arginines are shown in online version of this article as Supplementary material (Table 10, .xlsx file).

Table 11

Detected peptides in a tryptic digest of standard mTf analyzed by µLC–MS–TOF.

Detected peptides in mTf standard
VPDK
TVK
WCAVSEHENTK
CISFR
DHMK
TVLPPDGPR
LACVK
K
TSYPDCIK
AISASEADAMTLDGGWVYDA GLTPNNLKPVAAEFYGSVEH PQTYYYAVAVVKX
K
GTDFQLNQLEGK
K
SCHTGLGR
SAGWVIPIGLLFCK
LSEPR
SPLEK
AVSSFFSGSCVPCADPVAFP K
LCQLCPGCGCSSTQPFFGYV GAFK
CLK
DGGGDVAFVK
HTTIFEVLPEK
ADR
DQYELLCLDNTR
KPVDQYEDCYLAR
IPSHAVVAR
K
NNGKX
EDLIWEILK
VAQEHFGK
GK
SK
DFQLFSSPLGK
DLLFK
DSAFGLLR
VPPR
MDYR
LYLGHNYVTAIR
NQQEGVCPEGSIDNSPVK
WCALSHLER
TK
CDEWSIISEGK
IECESAETTEDCIEK
IVNGEADAMTLDGGHAYIAGQCGLVPVMAEYYESSNCAIPSQQGIFPK
GYYAVAVVK
ASDTSITWNNLK
GK
K
SCHTGVDR
TAGWNIPMGMLYNR
INHCK
FDEFFSQGCAPGYEK
CAPNNK
EEYNGYTGAFR
CLVEK
GDVAFVK
HQTVLDNTEGK
NPAEWAK
NLK
QEDFELLCPDGTR
KPVK
DFASCHLAQAPNHVVVSR
K
EK
AAR
VK
AVLTSQETLFGGSDCTGNFC LFK
STTK
DLLFR
DDTKX
CFVK
LPEGTTPEK
YLGAEYMQSVGNMR
K
CSTSR
LLEACTFHK
H
Total number of amino acids678
Number of amino acids detected618
Coverage (%)91
Table 12

Normalized peak area and %RSD of Tf glycopeptide glycoforms detected in the spots of spleen protein extracts subjected to 2D electrophoretic separation and in-gel tryptic digestion.

GlycoformsSpot 532
Spot 533
Spot 536
Spot 537
Spot 539
Anorm%RSDAnorm%RSDAnorm%RSDAnorm%RSDAnorm%RSD
2Ant/1NeuGc7.76.117.018.115.46.4
2Ant/1NeuGc1Fuc5.51.2
2Ant/2NeuGc54.73.756.97.154.97.976.55.5137.80.8
2Ant/2NeuGc1Fuc29.86.725.97.516.220.726.117.1
2Ant/3NeuGc17.75.529.815.68.74.9
2Ant/3NeuGc1Fuc2.63.3

Anorm: normalized peak areas were calculated as: (Glycoform peak area/peptide 354–364 (CDEWSIISEGK) peak area)×100.

Experimental design, materials and methods

Mice

WT mice were purchased from Harlan Ibérica (Barcelona, Spain). Mice deficient in CD38 (CD38-KO) were backcrossed onto the B6 background for more than 12 generations, as described previously [3]. All studies with live animals were approved by the IPBLN and Universidad de Cantabria Institutional Laboratory Animal Care and Use Committees.

Induction and assessment of arthritis

For the induction of CIA, 8–12 weeks-old male mice were immunized as previously described [4], [5].

Protein extraction from spleen preparations

Proteins were extracted from spleen by using the MicroRotofor Lysis Kit (for mammalian tissues and cells) (Bio-Rad, Ref #163-2141), following the manufacturer׳s instructions, which includes the use of mini-grinders for effective disruption of cells and tissues. The excess of salts and other contaminants were removed using the Bio-Rad׳s ReadyPrep 2-D cleanup kit. Samples were then resuspended in a DIGE-compatible buffer (7 M urea, 2 M thiourea, 4% CHAPS, 20 mM Tris, pH 8.5), quantified using the RC DC assay, and kept at −20 °C until further use.

Design of DiGE experiments

Unless otherwise indicated in each DiGE experiment conducted, four biological replicates of each condition were compared, comprising protein samples derived from four CD38-KO mice and four WT mice as previously described [1], [6].

DiGE labeling and two-dimensional gel electrophoresis

Samples were aliquoted at 45 μg, and the pooled internal standard was made with 23 μg of each of the sixteen test samples combined. The proteins were labeled with 400 pmol (in 1 μL of anhydrous DMF) of CyDye per 50 μg of protein as per the manufacturer׳s instructions (GE Healthcare). After labeling, the appropriate samples were combined for each gel. Each combined sample (~50 μL) was made up to 200 μL with Readyprep Rehydration/Sample buffer (8 M urea, 2% CHAPS, 50 mM dithiothreitol (DTT), 0.2% (w/v) Bio-Lyte® 3/10 ampholytes, and Bromophenol Blue (trace)). 2-DE was carried out using the Protean IEF cell and Criterion electrophoresis cell systems (Bio-Rad, Hercules, CA, USA) as previously described [7], with the following modifications: (1) First-dimension IPG strips (Bio-Rad: 11 cm, linear pH 3-10 gradient); (2) Active in-gel rehydration at 50 V, 12 h at 20 °C; (3) The IPG strips were focused in a one-step procedure, at 8000 V for a total of 35,000  Vh at 20 °C with a current limit of 50 μA/strip. After electrophoresis, one of the gels was pre-scanned using the Typhoon 9400 variable mode imager at each of the appropriate CyDye excitation wavelengths (Cy3 (532 nm), Cy5 (633 nm), Cy2 (488 nm)), in order to determine the appropriate laser intensity for each CyDye. Thereafter, each of the analytical gels was scanned at this optimum laser intensity at a 2resolution of 100 μm. Gels were then fixed and stained with SYPRO Ruby (Bio-Rad) and re-scanned using the 488 nm laser. Scanned images were analyzed using the DeCyder7.0 software (GE Healthcare) using the Differential In-gel Analysis (DIA) module to detect and normalize the protein spots. Standard was used to normalize gels by calculating the standardized abundance of each spot, i.e., the ratio of either Cy3 or Cy5 signal to that of Cy2.

Protein identification by MALDI-TOF/TOF MS/MS

In-gel digestion of proteins has been described previously [8]. A set of protein spots were identified by MS/MS using a 4800 MALDI-TOF/TOF Analyzer (AB SCIEX) in automatic mode with the settings described previously [6]. Protein identification was assigned by peptide mass fingerprinting and confirmed by MS/MS analysis of at least three peptides in each sample. Mascot 2.0 search engine (Matrixscience) was used for protein identification running on GPS software (Applied Biosystems) against the SwissProt Mus musculus database (uniprot_sprot_26042011.fasta). The search setting allowed one missed cleavage with the selected trypsin enzyme, a MS/MS fragment tolerance of 0.2 Da and a precursor mass tolerance of 100 ppm. Other spots were identified by MS/MS using a MALDI TOF/TOF UltrafleXtreme (Bruker) in manual mode as previously described [6]. Fragment selection criteria were a minimum S/N ratio of 15, a maximum number of peaks set at 200. For each precursor selected for MS/MS analysis, fragment mass values in the range from 13 Da to 4 Da below precursor mass were used to peptide identification. Protein identification was assigned by peptide mass fingerprinting and confirmed by MS/MS analysis of 5 peptides. Mascot Server 2.4 (Matrixscience) and ProteinScape 3.1 (Bruker) were used for protein identification against the SwissProt Mus musculus database (SwissProt_2015_06.fasta and NCBInr_20150409.fasta). The search setting allowed two missed cleavage with the selected trypsin enzyme, fixed modification was cysteine carbamidomethylation and variable modification was methionine oxidation, a MS/MS fragment tolerance of 0.5 Da and a precursor mass tolerance of 50 ppm, unless otherwise indicated. The MS spectra of the identified proteins were further examined in order to detect the presence of citrullinated proteins. Protein citrullination (o deimination) is the enzymatic conversion of peptidyl-arginine residues to peptidyl-citruline, mediated by the family of calcium-dependent peptidylarginine deiminases (PADs) [9]. The search setting for this PTM with MASCOT was performed as in the previous paragraph, including as variable modification the deamination of arginine, with the following considerations [10]: (a) for one citrullinated arginine, the peptide theoretical mass increase is 0.98 Da and the modified peptide, losing one amino group, becomes more acidic; (b) citrullinated arginine residues are not likely to be cleaved by trypsin, so that a minimum number of one missed cleavage must be specified; (c) a peptide that includes a C-terminal citrullinated arginine must be rejected; (d) citrullinated peptides generate an unusual isotopic mass cluster as compared with that of unmodified peptides.

μLC–TOF–MS

The µLC–TOF–MS experiments were performed in a 1200 series capillary liquid chromatography system coupled to a 6220 oa-TOF mass spectrometer with an orthogonal G1385–44300 interface (Agilent Technologies). LC and MS control, separation, data acquisition and processing were performed using MassHunter workstation software (Agilent Technologies). The oa-TOF mass spectrometer was tuned and calibrated following the manufacturer׳s instructions. Once a day, or even twice a day when required, a “Quick Tune” of the instrument was carried out in positive mode followed by a mass-axis calibration to ensure accurate mass assignments. In order to enhance detection sensitivity of glycopeptides, no internal recalibration was used [11]. MS measurement parameters were as described in a previous work [12]: capillary voltage 4000 V, drying gas (N2) temperature 200 °C,drying gasflow rate 4 L min−1,nebulizer gas (N2) 15 psig, fragmentor voltage 215 V, skimmer voltage 60 V, OCT 1 RF Vpp voltage 300 V. Data were collected in profile (continuum) at 1 spectrum s−1 (approx. 10,000 transients/spectrum) between m/z 100 and 3200, working in the highest resolution mode (4 GHz). For separation, a Zorbax 300SB-C18 column (3.5 m particle diameter, 300 A° pore diameter, 150 mM×0.3 mm LT×id, Agilent Technologies) was used. Experiments were performed at room temperature with gradient elution at a flow rate of 4 µL min−1. Eluting solvents were A: water with 0.1% (v/v) formic acid, and B: acetonitrile with 0.1% (v/v) formic acid. Solvents were degassed for 10 min by sonication before use. The optimum elution program was: solvent B from 10% to 60% (v/v) within 45 min as linear gradient, followed by cleaning and re-equilibration steps of B: 60% to 100% (v/v) (5 min), 100% (v/v) (10 min), 100% to 10% (v/v) (5 min) and 10% (v/v) (10 min). Before analysis, samples were filtered using a 0.22 µm polyvinylidene difluoride centrifugal filter (Ultrafree-MC, Millipore, Bedford, MA, USA) at 12,000 rpm for 4 min. Sample injection was performed with an autosampler refrigerated at 4 °C and the injection volume was 1 μL when analyzing Tf isolated from serum samples and digested with trypsin, and 5 μL when analyzing Tf in-gel digests.

μLC–TOF–MS data analysis

Prior to data analysis, a database with the exact monoisotopic mass of the different glycopeptide glycoforms of mouse Tf was created using Excel. To calculate the monoisotopic mass of each glycopeptide glycoform, it was necessary to calculate the elemental composition of all the glycopeptides taking into account the peptide and glycan contribution. First, the peptide sequence of mouse Tf was obtained from UniProt Knowledgebase (Q921l1), which also includes information about which cysteines and asparagines are involved in disulfide bonds and in N-glycosylation points, respectively. Afterwards, the theoretical sequence of each peptide and glycopeptide that would be obtained after tryptic digestion is obtained using the proteomic tool PeptideMass from the Expasy bioinformatics resource program. Subsequently, using the ProtParam tool from Expasy the elemental composition of the peptide sequence of the glycopeptide is obtained. Furthermore, the elemental composition of each glycan is calculated as the sum of the elemental composition of each monosaccharide that forms the glycan. Ion source webpage was used to obtain the elemental composition of each monosaccharide. Finally, the elemental composition of the peptide is added to obtain the molecular formula of each possible glycopeptides glycoform and thus, the monoisotopic mass with four decimals. Afterwards, the mass-to-charge values (m/z) for each glycopeptide glycoform are calculated up to a z value of 5 considering proton adducts (i.e. [M+H]+, [M+2H]2+, [M+3H]3+, [M+4H]4+ and [M+5H]5+) Finally, the data analysis is carried out using the software MassHunter Qualitative (Agilent Technologies). All the previously calculated m/z values for each glycopeptide glycoform are extracted together to obtain an extracted ion chromatogram (EIC) of that glycopeptide specie, as can be observed in Fig. 1, which shows the EIC for some glycopeptide glycoforms in three different samples. If more than one of the extracted masses is detected in one chromatographic peak of the EIC, the presence of the corresponding glycopeptide glycoforms can be confirmed. Table 1, Table 2 can be found in the online version of this article (.xlsx files). They show the list of protein species identified by MS/MS, displaying the sequence of matched and fragmented peptides of a given protein. Ion scores and confidence intervals of the fragmented peptides are also shown.
Subject areaBiology
More specific subject areaProteomics and glycoproteomics
Type of dataTables, figures and raw data
How data was acquiredScanned 2D-DiGE images were analyzed using the DeCyder7.0 software (GE Healthcare) using the Differential In-gel Analysis (DIA) module to detect and normalize the protein spots. Protein relative abundance across all samples and statistical analyses were performed using the Biological Variation Analysis (BVA) module of the DeCyder software. MS data for protein identification was acquired using a MALDI TOF/TOF UltrafleXtreme (Bruker), or a 4800 MALDI-TOF/TOF Analyzer (AB SCIEX). μLC–TOF–MS data for the analysis of the glycopeptides glycoforms of Tf was acquired with a 1200 series capillary liquid chromatography system (Agilent Technologies) coupled to a 6220 oa-TOF LC/MS mass spectrometer with an orthogonal G1385-44300 interface (Agilent Technologies).
Data formatAnalyzed (excel files and word tables) and raw data
Experimental factorsMice with Collagen-induced arthritis, or with chronic inflammation, or with no treatment. Protein extraction and/or purification from spleen or serum samples. CyDye labeling. 2-D gel electrophoresis.
Experimental featuresProtein extracts from mice subjected to different experimental conditions were analyzed by 2D-DiGE, and protein species that differed in abundance were identified by MS/MS. PTMs such as citrullination of the identified proteins, or glycosylation of Tf species were further analyzed by MS.
Data source locationUB: Barcelona; UCO: Córdoba; IPBLN: Granada.
Data accessibilityData is within this article. Data also available at the ProteomeXchange Consortium via the PRIDE partner repository, PRIDE: PXD002644, PRIDE: PXD002643, PRIDE: PXD003183 and PRIDE: PXD003163.
  12 in total

1.  Capillary electrophoresis time-of-flight mass spectrometry for a confident elucidation of a glycopeptide map of recombinant human erythropoietin.

Authors:  Estela Giménez; Raquel Ramos-Hernan; Fernando Benavente; José Barbosa; Victoria Sanz-Nebot
Journal:  Rapid Commun Mass Spectrom       Date:  2011-08-30       Impact factor: 2.419

2.  Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: a proteomic signature for circulating low-density granulocytes.

Authors:  Esther J Pavón; Sonia García-Rodríguez; Esther Zumaquero; Rubén Perandrés-López; Antonio Rosal-Vela; Antonio Lario; Victoria Longobardo; Montserrat Carrascal; Joaquín Abián; José-Luis Callejas-Rubio; Norberto Ortego-Centeno; Mercedes Zubiaur; Jaime Sancho
Journal:  J Proteomics       Date:  2011-12-30       Impact factor: 4.044

Review 3.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease.

Authors:  Erik R Vossenaar; Albert J W Zendman; Walther J van Venrooij; Ger J M Pruijn
Journal:  Bioessays       Date:  2003-11       Impact factor: 4.345

4.  Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms.

Authors:  Esther J Pavón; Pilar Muñoz; Antonio Lario; Victoria Longobardo; Montserrat Carrascal; Joaquín Abián; Ana B Martin; Salvador A Arias; José-Luis Callejas-Rubio; Ricardo Sola; Francisco Navarro-Pelayo; Enrique Raya-Alvarez; Norberto Ortego-Centeno; Mercedes Zubiaur; Jaime Sancho
Journal:  Proteomics       Date:  2006-04       Impact factor: 3.984

5.  Analysis of human transferrin glycopeptides by capillary electrophoresis and capillary liquid chromatography-mass spectrometry. Application to diagnosis of alcohol dependence.

Authors:  Albert Barroso; Estela Giménez; Fernando Benavente; José Barbosa; Victoria Sanz-Nebot
Journal:  Anal Chim Acta       Date:  2013-10-09       Impact factor: 6.558

6.  Identification of multiple transferrin species in the spleen and serum from mice with collagen-induced arthritis which may reflect changes in transferrin glycosylation associated with disease activity: The role of CD38.

Authors:  A Rosal-Vela; A Barroso; E Giménez; S García-Rodríguez; V Longobardo; J Postigo; M Iglesias; A Lario; J Merino; R Merino; M Zubiaur; V Sanz-Nebot; J Sancho
Journal:  J Proteomics       Date:  2015-11-27       Impact factor: 4.044

7.  Mice deficient in CD38 develop an attenuated form of collagen type II-induced arthritis.

Authors:  Jorge Postigo; Marcos Iglesias; Daniela Cerezo-Wallis; Antonio Rosal-Vela; Sonia García-Rodríguez; Mercedes Zubiaur; Jaime Sancho; Ramón Merino; Jesús Merino
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

8.  Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen.

Authors:  Julia J Inglis; Gabriel Criado; Mino Medghalchi; Melanie Andrews; Ann Sandison; Marc Feldmann; Richard O Williams
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes.

Authors:  Vincent Goëb; Marlène Thomas-L'Otellier; Romain Daveau; Roland Charlionet; Patrice Fardellone; Xavier Le Loët; François Tron; Danièle Gilbert; Olivier Vittecoq
Journal:  Arthritis Res Ther       Date:  2009-03-10       Impact factor: 5.156

10.  ProteomeXchange provides globally coordinated proteomics data submission and dissemination.

Authors:  Juan A Vizcaíno; Eric W Deutsch; Rui Wang; Attila Csordas; Florian Reisinger; Daniel Ríos; José A Dianes; Zhi Sun; Terry Farrah; Nuno Bandeira; Pierre-Alain Binz; Ioannis Xenarios; Martin Eisenacher; Gerhard Mayer; Laurent Gatto; Alex Campos; Robert J Chalkley; Hans-Joachim Kraus; Juan Pablo Albar; Salvador Martinez-Bartolomé; Rolf Apweiler; Gilbert S Omenn; Lennart Martens; Andrew R Jones; Henning Hermjakob
Journal:  Nat Biotechnol       Date:  2014-03       Impact factor: 54.908

View more
  1 in total

1.  Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity.

Authors:  Ida Hafstrand; Daniel Badia-Martinez; Benjamin John Josey; Melissa Norström; Jérémie Buratto; Sara Pellegrino; Adil Doganay Duru; Tatyana Sandalova; Adnane Achour
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.